FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileDirexion Daily Pharmaceutical & Medical Bull 3X Shares
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
PILL
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF AnalysisComprehensive ETF analysis for Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisPILL
PILL
Direxion Daily Pharmaceutical & Medical Bull 3X Shares
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
PILL
  1. Home
  2. Screener
  3. Direxion Daily Pharmaceutical & Medical Bull 3X SharesPILLETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

ETF
🇺🇸PILL•AMEX•Equity
Fund size (USD)
$18.14M
Expense Ratio
1.22%
Yield (12 mo)
0.41%
Holdings
50

Your view on PILL

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

ETFDirexion
🇺🇸PILL•AMEX•Equity
Fund size (USD)
$18.14M
Expense Ratio
1.22%
Yield (12 mo)
0.41%
Holdings
50
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) is an Equity fund from Direxion, listed since 2017, with $18.1M in assets under management, a 1.22% expense ratio and a NAV of $16.49 USD.

Overview for Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Fund Type
ETF
Fund Issuer
Direxion
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
November 15, 2017
Domicile
US
Website
direxion.com/product/daily-pharmaceutical-medical-bull-3x-etf
Fund Type
ETF
Fund Issuer
Direxion
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
November 15, 2017
Domicile
US
Website
direxion.com/product/daily-pharmaceutical-medical-bull-3x-etf
Fund Type
ETF
Fund Issuer
Direxion
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
November 15, 2017
Domicile
US
Website
direxion.com/product/daily-pharmaceutical-medical-bull-3x-etf

About this fund

The Direxion Daily Pharmaceutical & Medical Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. There is no guarantee the fund will achieve its stated investment objective.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

1.22%

Yield (12 mo)

0.41%

Fund size

$18.14M

Fund Details

NAV$16.49 USD
Holdings50
Average Volume59.2K
Inception DateNovember 15, 2017
Asset ClassEquity
Fund IssuerDirexion
DomicileUS
ISINUS25460E6462
CUSIP25460E646
NAV CurrencyUSD

Expense Ratio

1.22%

Dividend Yield (TTM)

0.41%

Assets Under Management

$18.14M

NAV

$16.49 USD

Holdings

50

Average Volume

59.2K

Inception Date

November 15, 2017

Asset Class

Equity

Fund Issuer

Direxion

Domicile

US

ISIN

US25460E6462

CUSIP

25460E646

NAV Currency

USD

Expense Ratio

1.22%

Dividend Yield (TTM)

0.41%

Assets Under Management

$18.14M

NAV

$16.49 USD

Holdings

50

Average Volume

59.2K

Inception Date

November 15, 2017

Asset Class

Equity

Fund Issuer

Direxion

Domicile

US

ISIN

US25460E6462

CUSIP

25460E646

NAV Currency

USD

Distributions · last 12 months

Quarterly · 4 payments

Ex-datePaidAmount
Sep 22, 2026Sep 29, 2026$0.0009
Jun 23, 2026Jun 30, 2026$0.0152
Mar 24, 2026Mar 31, 2026$0.0109
Dec 23, 2025Dec 31, 2025$0.0326
Total, 12 months$0.06 a share

Dividend yield (TTM) 0.41% = $0.06 paid per share in the 12 months to Nov 20, 2026 ÷ the $14.55 price. Past distributions; future payments can differ.

Data last updated: Nov 16, 2026, 08:10 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

67 positions
1—SPSIPH SWAP ASSET LEG (SPSIPHCTL)
32.02%
2—SPSIPH SWAP ASSET LEG (SPSIPHBCL)
18.80%
3—SPSIPH SWAP ASSET LEG (SPSIPHUBL)
16.01%
4—GOLDMAN FINL SQ TRSRY INST 506
6.35%
5—DREYFUS GOVT CASH MAN INS
4.05%
6—GOLDMAN SACHS FIN GOV 465 INSTITUT
3.21%
7—SPSIPH SWAP ASSET LEG (SPSIPHJPL)
2.72%
8XERSXERIS BIOPHARMA HOLDINGS INC
0.78%
9MANEVERADERMICS INC
0.45%
10AMRXAMNEAL PHARMACEUTICALS INC
0.45%
11VTRSVIATRIS INC
0.44%
12LLYELI LILLY & CO
0.44%
13MAZEMAZE THERAPEUTICS INC
0.43%
14PRGOPERRIGO CO PLC
0.41%
15RPRXROYALTY PHARMA PLC- CL A
0.41%

Concentration

Top 10 Weight84.83%
1—SPSIPH SWAP ASSET LEG (SPSIPHCTL)
32.02%
2—SPSIPH SWAP ASSET LEG (SPSIPHBCL)
18.80%
3—SPSIPH SWAP ASSET LEG (SPSIPHUBL)
16.01%
4—GOLDMAN FINL SQ TRSRY INST 506
6.35%
5—DREYFUS GOVT CASH MAN INS
4.05%
6—GOLDMAN SACHS FIN GOV 465 INSTITUT
3.21%
7—SPSIPH SWAP ASSET LEG (SPSIPHJPL)
2.72%
8XERSXERIS BIOPHARMA HOLDINGS INC
0.78%
9MANEVERADERMICS INC
0.45%
10AMRXAMNEAL PHARMACEUTICALS INC
0.45%
11VTRSVIATRIS INC
0.44%
12LLYELI LILLY & CO
0.44%
13MAZEMAZE THERAPEUTICS INC
0.43%
14PRGOPERRIGO CO PLC
0.41%
15RPRXROYALTY PHARMA PLC- CL A
0.41%

Top 10 Weight

84.83%

1—SPSIPH SWAP ASSET LEG (SPSIPHCTL)
32.02%$17.08M
2—SPSIPH SWAP ASSET LEG (SPSIPHBCL)
18.80%$10.03M
3—SPSIPH SWAP ASSET LEG (SPSIPHUBL)
16.01%$8.54M
4—GOLDMAN FINL SQ TRSRY INST 506
6.35%$3.39M
5—DREYFUS GOVT CASH MAN INS
4.05%$2.16M
6—GOLDMAN SACHS FIN GOV 465 INSTITUT
3.21%$1.71M
7—SPSIPH SWAP ASSET LEG (SPSIPHJPL)
2.72%$1.45M
8XERSXERIS BIOPHARMA HOLDINGS INC
0.78%$416.6K
9MANEVERADERMICS INC
0.45%$241.2K
10AMRXAMNEAL PHARMACEUTICALS INC
0.45%$239.6K
11VTRSVIATRIS INC
0.44%$232.9K
12LLYELI LILLY & CO
0.44%$232.4K
13MAZEMAZE THERAPEUTICS INC
0.43%$226.9K
14PRGOPERRIGO CO PLC
0.41%$216.2K
15RPRXROYALTY PHARMA PLC- CL A
0.41%$216.0K

Top 10 Weight

84.83%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on19 funds
FundAsset classExpense ratioAssetsHoldings
PILLDirexion Daily Pharmaceutical & Medical Bull 3X SharesThis fundEquity1.22%$18M50

Comparable funds

  • BUYOKraneShares Man Buyout Beta Index ETFEquity0.89%$17M305
  • CGROCoreValues Alpha Greater China Growth ETFEquity0.85%$2M32
  • INOVIntl Developed Power Buffer ETFEquity0.85%$49M6
  • JUNZTrueShares Structured Outcome (June) ETFEquity0.79%$30M7
  • MRGRProShares - Merger ETFEquity0.75%$15M52
  • PSCMInvesco S&P SmallCap Materials ETFEquity0.29%$17M27
  • QIDXIndexperts Quality Earnings Focused ETFEquity0.50%$40M130

More Direxion ETFs

  • ORCSDirexion Daily ORCL Bear 1X ETFLeveraged/Inverse0.99%$6M0
  • ORCUDirexion Daily ORCL Bull 2X ETFEquity0.99%$102M0
  • PALDDirexion Daily PANW Bear 1X SharesLeveraged/Inverse2.33%$4M3
  • PALUDirexion Daily PANW Bull 2X SharesEquity1.48%$19M4
  • PLTUDirexion Daily PLTR Bull 2X SharesEquity0.97%$220M0
  • PYPUDirexion Daily PYPL Bull 2X ETFLeveraged/Inverse0.99%$2M0
  • QCMDDirexion Daily QCOM Bear 1X ETFLeveraged/Inverse2.76%$2M3
  • QCMUDirexion Daily QCOM Bull 2X ETFEquity2.44%$19M6
  • QQQDDirexion Daily Magnificent 7 Bear 1X SharesLeveraged/Inverse1.08%$26M7
  • QQQEDirexion NASDAQ-100 Equal Weighted Index SharesEquity0.35%$1.4B103
  • QQQUDirexion Daily Magnificent 7 Bull 2X SharesEquity1.00%$65M13
  • RETLDirexion Daily Retail Bull 3X SharesEquity0.96%$30M85
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.